Release date: 3 May 2021
Promoter – Financial Intermediary
DRAEGERWERK AG & CO KGAALocation
Description
The project concerns the Promoter's corporate research and development (R&D) programme in its medical division for the period 2021-2023, with a particular focus on connected health devices.
Objectives
The project's emphasis on connected health devices follows the trend of therapy automation in hospitals through diagnostic and therapeutic assistance systems. Since the outbreak of COVID-19, the relevance and demand for connected health devices has significantly increased.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 100 million
Total cost (Approximate amount)
EUR 225 million
Environmental aspects
The project concerns investments in research and development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) 2014/52/EU amending the EIA Directive 2011/92/EC. Full environmental details will be verified during the appraisal.
Procurement
The Promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.
Status
Signed - 14/04/2021
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).